UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 151

Sortiert nach

Pycnogenol® Supplementation Prevents Recurrent Urinary Tract Infections/Inflammation and Interstitial Cystitis

Evidence-based complementary and alternative medicine, 2021, Vol.2021, p.1-8

2021

Volltextzugriff (PDF)

Effects of a curcumin-based supplementation in asymptomatic subjects with low bone density: a preliminary 24-week supplement study

European review for medical and pharmacological sciences, 2017-04, Vol.21 (7), p.1684

2017

Volltextzugriff (PDF)

Highly standardized cranberry extract supplementation (Anthocran®) as prophylaxis in young healthy subjects with recurrent urinary tract infections

European review for medical and pharmacological sciences, 2017-01, Vol.21 (2), p.389

2017

Volltextzugriff (PDF)

Movardol® (N-acetylglucosamine, Boswellia serrata, ginger) supplementation in the management of knee osteoarthritis: preliminary results from a 6-month registry study

European review for medical and pharmacological sciences, 2016-12, Vol.20 (24), p.5198

2016

Volltextzugriff (PDF)

Supplementation with high titer cranberry extract (Anthocran®) for the prevention of recurrent urinary tract infections in elderly men suffering from moderate prostatic hyperplasia: a pilot study

European review for medical and pharmacological sciences, 2016-12, Vol.20 (24), p.5205

2016

Volltextzugriff (PDF)

Bilberry extracts are not created equal: the role of non anthocyanin fraction. Discovering the "dark side of the force" in a preliminary study

European review for medical and pharmacological sciences, 2016-06, Vol.20 (11), p.2418

2016

Volltextzugriff (PDF)

Pycnogenol® improves cognitive function, attention, mental performance and specific professional skills in healthy professionals aged 35-55

Journal of neurosurgical sciences, 2014-12, Vol.58 (4), p.239

2014

Volltextzugriff (PDF)

Pycnogenol® Supplementation Improves Health Risk Factors in Subjects with Metabolic Syndrome

Phytotherapy research, 2013-10, Vol.27 (10), p.1572-1578

2013

Volltextzugriff (PDF)

A novel lecithin based delivery form of Boswellic acids (Casperome®) for the management of osteo-muscular pain: a registry study in young rugby players

European review for medical and pharmacological sciences, 2016-10, Vol.20 (19), p.4156

2016

Volltextzugriff (PDF)

Managing ulcerative colitis in remission phase: usefulness of Casperome®, an innovative lecithin-based delivery system of Boswellia serrata extract

European review for medical and pharmacological sciences, 2016-06, Vol.20 (12), p.2695

2016

Volltextzugriff (PDF)

Supplementation with a lecithin-based delivery form of Boswellia serrata extract (Casperome®) controls symptoms of mild irritable bowel syndrome

European review for medical and pharmacological sciences, 2017-05, Vol.21 (9), p.2249

2017

Volltextzugriff (PDF)

Aescin-based topical formulation to prevent foot wounds and ulcerations in diabetic microangiopathy

European review for medical and pharmacological sciences, 2016-10, Vol.20 (20), p.4337

2016

Volltextzugriff (PDF)

Pycnogenol® and Centella Asiatica for asymptomatic atherosclerosis progression

International angiology, 2014-02, Vol.33 (1), p.20

2014

Volltextzugriff (PDF)

Pycnogenol® and Centella asiatica in the management of asymptomatic atherosclerosis progression

International angiology, 2015-04, Vol.34 (2), p.150

2015

Volltextzugriff (PDF)

The COFU3 Study. Improvement in cognitive function, attention, mental performance with Pycnogenol® in healthy subjects (55-70) with high oxidative stress

Journal of neurosurgical sciences, 2015-12, Vol.59 (4), p.437

2015

Volltextzugriff (PDF)

Cranberry supplementation in the prevention of non-severe lower urinary tract infections: a pilot study

European review for medical and pharmacological sciences, 2015-01, Vol.19 (1), p.77

2015

Volltextzugriff (PDF)

A natural pharma standard supplement formulation to control treatment-related toxicity and oxidative stress in genitourinary cancer: a preliminary study

European review for medical and pharmacological sciences, 2017-09, Vol.21 (18), p.4196

2017

Volltextzugriff (PDF)

Improved management of primary chronic fatigue syndrome with the supplement French oak wood extract (Robuvit®): a pilot, registry evaluation

Panminerva medica, 2014-03, Vol.56 (1), p.63

2014

Volltextzugriff (PDF)

Management of Varicose Veins and Chronic Venous Insufficiency in a Comparative Registry with Nine Venoactive Products in Comparison with Stockings

The International journal of angiology, 2017-09, Vol.26 (3), p.170-178

2017

Volltextzugriff (PDF)

Effectiveness of a novel boswellic acids delivery form (Casperome®) in the management of grade II ankle sprains due to sport trauma - a registry study

European review for medical and pharmacological sciences, 2017-10, Vol.21 (20), p.4726

2017

Volltextzugriff (PDF)

Improvement of signs and symptoms of chronic venous insufficiency and microangiopathy with Pycnogenol ®: A prospective, controlled study

Phytomedicine (Stuttgart), 2010-09, Vol.17 (11), p.835-839

2010

Volltextzugriff (PDF)

Effects of Pycnogenol® on endothelial dysfunction in borderline hypertensive, hyperlipidemic, and hyperglycemic individuals: the borderline study

International angiology, 2015-02, Vol.34 (1), p.43

2015

Volltextzugriff (PDF)

Robuvit® (Quercus robur extract) supplementation in subjects with chronic fatigue syndrome and increased oxidative stress. A pilot registry study

Journal of neurosurgical sciences, 2015-06, Vol.59 (2), p.105

2015

Volltextzugriff (PDF)

Treatment of osteoarthritis with Pycnogenol®. The SVOS (San Valentino osteo-arthrosis study). evaluation of signs, symptoms, physical performance and vascular aspects

Phytotherapy research, 2008-04, Vol.22 (4), p.518-523

2008

Volltextzugriff (PDF)

A controlled study shows daily intake of 50 mg of French Pine Bark Extract (Pycnogenol®) lowers plasma reactive oxygen metabolites in healthy smokers

Minerva medica, 2013-08, Vol.104 (4), p.439

2013

Volltextzugriff (PDF)

1 – 25 von 151

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(73)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(131)
Female
(105)
Male
(105)
Middle Aged
(95)
Life Sciences & Biomedicine
(76)
Science & Technology
(76)
Adult
(69)
Treatment Outcome
(53)
Cardiovascular System & Cardiology
(45)
Peripheral Vascular Disease
(43)
Biological And Medical Sciences
(36)
Medical Sciences
(36)
Aged
(33)
Pilot Projects
(30)
Registries
(29)
Flavonoids - Therapeutic Use
(26)
Blood And Lymphatic Vessels
(25)
Cardiology. Vascular System
(25)
Diseases Of The Peripheral Vessels. Diseases Of The Vena Cava. Miscellaneous
(25)
Dietary Supplements
(24)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pycnogenol® Supplementation Prevents Recurrent Urinary Tract Infections/Inflammation and Interstitial Cystitis

Effects of a curcumin-based supplementation in asymptomatic subjects with low bone density: a preliminary 24-week supplement study

Highly standardized cranberry extract supplementation (Anthocran®) as prophylaxis in young healthy subjects with recurrent urinary tract infections

Movardol® (N-acetylglucosamine, Boswellia serrata, ginger) supplementation in the management of knee osteoarthritis: preliminary results from a 6-month registry study

Supplementation with high titer cranberry extract (Anthocran®) for the prevention of recurrent urinary tract infections in elderly men suffering from moderate prostatic hyperplasia: a pilot study

Bilberry extracts are not created equal: the role of non anthocyanin fraction. Discovering the "dark side of the force" in a preliminary study

Pycnogenol® improves cognitive function, attention, mental performance and specific professional skills in healthy professionals aged 35-55

Pycnogenol® Supplementation Improves Health Risk Factors in Subjects with Metabolic Syndrome

A novel lecithin based delivery form of Boswellic acids (Casperome®) for the management of osteo-muscular pain: a registry study in young rugby players

Managing ulcerative colitis in remission phase: usefulness of Casperome®, an innovative lecithin-based delivery system of Boswellia serrata extract

Supplementation with a lecithin-based delivery form of Boswellia serrata extract (Casperome®) controls symptoms of mild irritable bowel syndrome

Aescin-based topical formulation to prevent foot wounds and ulcerations in diabetic microangiopathy

Pycnogenol® and Centella Asiatica for asymptomatic atherosclerosis progression

Pycnogenol® and Centella asiatica in the management of asymptomatic atherosclerosis progression

The COFU3 Study. Improvement in cognitive function, attention, mental performance with Pycnogenol® in healthy subjects (55-70) with high oxidative stress

Cranberry supplementation in the prevention of non-severe lower urinary tract infections: a pilot study

A natural pharma standard supplement formulation to control treatment-related toxicity and oxidative stress in genitourinary cancer: a preliminary study

Improved management of primary chronic fatigue syndrome with the supplement French oak wood extract (Robuvit®): a pilot, registry evaluation

Management of Varicose Veins and Chronic Venous Insufficiency in a Comparative Registry with Nine Venoactive Products in Comparison with Stockings

Effectiveness of a novel boswellic acids delivery form (Casperome®) in the management of grade II ankle sprains due to sport trauma - a registry study

Improvement of signs and symptoms of chronic venous insufficiency and microangiopathy with Pycnogenol ®: A prospective, controlled study

Effects of Pycnogenol® on endothelial dysfunction in borderline hypertensive, hyperlipidemic, and hyperglycemic individuals: the borderline study

Robuvit® (Quercus robur extract) supplementation in subjects with chronic fatigue syndrome and increased oxidative stress. A pilot registry study

Treatment of osteoarthritis with Pycnogenol®. The SVOS (San Valentino osteo-arthrosis study). evaluation of signs, symptoms, physical performance and vascular aspects

A controlled study shows daily intake of 50 mg of French Pine Bark Extract (Pycnogenol®) lowers plasma reactive oxygen metabolites in healthy smokers

Suchergebnisse filtern